Araştırma Makalesi
BibTex RIS Kaynak Göster

HIF-1α: a potential biomarker in obstructive sleep apnea

Yıl 2023, Cilt: 7 Sayı: 2, 139 - 143, 31.12.2023
https://doi.org/10.32571/ijct.1325830

Öz

Obstructive sleep apnea (OSA) is a common breathing disorder characterized by repeated obstruction of the upper airway during sleep. Although polysomnography (PSG) is the widely used method for the diagnosis of OSA, it is a time-consuming and expensive method. Because it requires at least 1 night stay in the hospital and technical personnel are needed. Therefore, it has been focused on biomarkers that can be easily detected in blood for the diagnosis of OSA. Some studies have highlighted the relationship between OSA and cancer in humans, and HIF-1 is an important regulator in this process. KDM3A is a histone demethylase that increases hypoxic gene expression. We aimed to evaluate whether the expression levels of HIF-1α and KDM3A genes could be useful predictors in patients with OSA. Our study included 50 patients with OSA and 50 healthy controls. qRT-PCR was used to detect mRNA levels of HIF-1α, KDM3A, and epithelial-mesenchymal transition (EMT) genes in the leukocyte samples. The expression level of the HIF-1α gene was found significantly higher in the OSA group compared to the controls, and no statistically significant difference was detected in the expression levels of the KDM3A and EMT genes.

Kaynakça

  • Young, T.; Palta, M.; Dempsey, J.; Skatrud, J.; Weber, S.; Badr, S. N Engl J Med. 1993, 328, 1230-5.
  • Chen, Y.H.; Keller, J.K.; Kang, J.H.; Hsieh, H.J.; Lin, H.C. J Clin Sleep Med. 2013, 9, 417-23.
  • Hunyor, I.; Cook, K.M. Am J Physiol Regul Integr Comp Physiol. 2018, 315, R669-R87.
  • Liu, C.; Wang, H.; Zhu, C.; Wang, S. J Clin Lab Anal. 2020, 34, e23545.
  • Toffoli, S.; Michiels, C. FEBS J. 2008, 275, 2991-3002.
  • Zhao, M.; Wang, S.; Zuo, A.; Zhang, J.; Wen, W.; Jiang, W. et al. Cell Mol Biol Lett. 2021, 26, 40.
  • Campos-Rodriguez, F.; Martinez-Garcia, M.A.; Martinez, M.; Duran-Cantolla, J.; de la Pena, M.; Masdeu, M.J. et al. Am J Respir Crit Care Med. 2013, 187, 99-105.
  • Marshall, N.S.; Wong, K.K., Cullen, S.R., Knuiman, M.W.; Grunstein, R.R. J Clin Sleep Med. 2014, 10, 355-62.
  • Ali, M.; Kowkuntla, S.; Delloro, D.J.; Galambos, C.; Hathi, D.; Janz, S. et al. Am J Physiol Regul Integr Comp Physiol. 2019, 316, R678-R86.
  • Gallego-Martin, T.; Farre, R.; Almendros, I.; Gonzalez-Obeso, E.; Obeso, A. Eur Respir J. 2017, 49, 1602111.
  • Malec, V.; Gottschald, O.R.; Li, S.; Rose, F.; Seeger, W.; Hanze, J. Free Radic Biol Med. 2010, 48, 1626-35.
  • Martinive, P.; Defresne, F.; Quaghebeur, E.; Daneau, G.; Crokart, N.; Gregoire, V. et al. FEBS J. 2009, 276, 509-18.
  • Toffoli, S.; Roegiers, A.; Feron, O.; Van Steenbrugge, M.; Ninane, N.; Raes, M. et al. Angiogenesis. 2009, 12, 47-67.
  • Wang, Z.; Si, L.Y. Ups J Med Sci. 2013, 118, 65-74.
  • Cao, D.; Hou, M.; Guan, Y.S., Jiang, M.; Yang, Y., Gou, H.F. BMC Cancer. 2009, 9, 432.
  • Turcotte, S., Desrosiers, R.R.; Béliveau, R. J Cell Sci. 2003, 116, 2247-60.
  • Krieg, A.J.; Rankin, E.B.; Chan, D.; Razorenova, O.; Fernandez, S.; Giaccia, A.J. Mol Cell Biol. 2010, 30, 344-53.
  • Cho, H.S.; Toyokawa, G.; Daigo, Y.; Hayami, S.; Masuda, K.; Ikawa, N. et al. 2012. Int J Cancer. 2012, 131, E179-89.
  • Yamada, D.; Kobayashi, S.; Yamamoto, H.; Tomimaru, Y.; Noda, T.; Uemura, M. et al. Ann Surg Oncol. 2012, 19 Suppl 3, S355-64.
  • Uemura, M.; Yamamoto, H.; Takemasa, I.; Mimori, K.; Hemmi, H.; Mizushima, T. et al. Clin Cancer Res. 2010,16, 4636-46.
  • Wang, J.; Wei, Q.; Wang, X.; Tang, S.; Liu, H.; Zhang, F. et al. Genes Dis. 2016, 3, 3-6.
  • Vu, T.; Datta, P.K. Cancers. 2017, 9, 171.
  • Jiang, J.; Tang, Y-l.; Liang X-h. Cancer Biol Ther. 2014, 11,714–723.
  • Merikallio, H.; T T.T.; Paakko, P.; Makitaro, R.; Kaarteenaho, R.; Lehtonen, S. et al. Int J Clin Exp Pathol. 2014, 7, 5846-54.
Yıl 2023, Cilt: 7 Sayı: 2, 139 - 143, 31.12.2023
https://doi.org/10.32571/ijct.1325830

Öz

Kaynakça

  • Young, T.; Palta, M.; Dempsey, J.; Skatrud, J.; Weber, S.; Badr, S. N Engl J Med. 1993, 328, 1230-5.
  • Chen, Y.H.; Keller, J.K.; Kang, J.H.; Hsieh, H.J.; Lin, H.C. J Clin Sleep Med. 2013, 9, 417-23.
  • Hunyor, I.; Cook, K.M. Am J Physiol Regul Integr Comp Physiol. 2018, 315, R669-R87.
  • Liu, C.; Wang, H.; Zhu, C.; Wang, S. J Clin Lab Anal. 2020, 34, e23545.
  • Toffoli, S.; Michiels, C. FEBS J. 2008, 275, 2991-3002.
  • Zhao, M.; Wang, S.; Zuo, A.; Zhang, J.; Wen, W.; Jiang, W. et al. Cell Mol Biol Lett. 2021, 26, 40.
  • Campos-Rodriguez, F.; Martinez-Garcia, M.A.; Martinez, M.; Duran-Cantolla, J.; de la Pena, M.; Masdeu, M.J. et al. Am J Respir Crit Care Med. 2013, 187, 99-105.
  • Marshall, N.S.; Wong, K.K., Cullen, S.R., Knuiman, M.W.; Grunstein, R.R. J Clin Sleep Med. 2014, 10, 355-62.
  • Ali, M.; Kowkuntla, S.; Delloro, D.J.; Galambos, C.; Hathi, D.; Janz, S. et al. Am J Physiol Regul Integr Comp Physiol. 2019, 316, R678-R86.
  • Gallego-Martin, T.; Farre, R.; Almendros, I.; Gonzalez-Obeso, E.; Obeso, A. Eur Respir J. 2017, 49, 1602111.
  • Malec, V.; Gottschald, O.R.; Li, S.; Rose, F.; Seeger, W.; Hanze, J. Free Radic Biol Med. 2010, 48, 1626-35.
  • Martinive, P.; Defresne, F.; Quaghebeur, E.; Daneau, G.; Crokart, N.; Gregoire, V. et al. FEBS J. 2009, 276, 509-18.
  • Toffoli, S.; Roegiers, A.; Feron, O.; Van Steenbrugge, M.; Ninane, N.; Raes, M. et al. Angiogenesis. 2009, 12, 47-67.
  • Wang, Z.; Si, L.Y. Ups J Med Sci. 2013, 118, 65-74.
  • Cao, D.; Hou, M.; Guan, Y.S., Jiang, M.; Yang, Y., Gou, H.F. BMC Cancer. 2009, 9, 432.
  • Turcotte, S., Desrosiers, R.R.; Béliveau, R. J Cell Sci. 2003, 116, 2247-60.
  • Krieg, A.J.; Rankin, E.B.; Chan, D.; Razorenova, O.; Fernandez, S.; Giaccia, A.J. Mol Cell Biol. 2010, 30, 344-53.
  • Cho, H.S.; Toyokawa, G.; Daigo, Y.; Hayami, S.; Masuda, K.; Ikawa, N. et al. 2012. Int J Cancer. 2012, 131, E179-89.
  • Yamada, D.; Kobayashi, S.; Yamamoto, H.; Tomimaru, Y.; Noda, T.; Uemura, M. et al. Ann Surg Oncol. 2012, 19 Suppl 3, S355-64.
  • Uemura, M.; Yamamoto, H.; Takemasa, I.; Mimori, K.; Hemmi, H.; Mizushima, T. et al. Clin Cancer Res. 2010,16, 4636-46.
  • Wang, J.; Wei, Q.; Wang, X.; Tang, S.; Liu, H.; Zhang, F. et al. Genes Dis. 2016, 3, 3-6.
  • Vu, T.; Datta, P.K. Cancers. 2017, 9, 171.
  • Jiang, J.; Tang, Y-l.; Liang X-h. Cancer Biol Ther. 2014, 11,714–723.
  • Merikallio, H.; T T.T.; Paakko, P.; Makitaro, R.; Kaarteenaho, R.; Lehtonen, S. et al. Int J Clin Exp Pathol. 2014, 7, 5846-54.
Toplam 24 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Biyokimya ve Hücre Biyolojisi (Diğer)
Bölüm Makale
Yazarlar

Derya Polat 0000-0002-1861-0099

Elif Pala 0000-0002-1690-3170

Filiz Gerçeker 0000-0003-1243-5880

Erken Görünüm Tarihi 4 Ocak 2024
Yayımlanma Tarihi 31 Aralık 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 7 Sayı: 2

Kaynak Göster

APA Polat, D., Pala, E., & Gerçeker, F. (2023). HIF-1α: a potential biomarker in obstructive sleep apnea. International Journal of Chemistry and Technology, 7(2), 139-143. https://doi.org/10.32571/ijct.1325830
AMA Polat D, Pala E, Gerçeker F. HIF-1α: a potential biomarker in obstructive sleep apnea. Int. J. Chem. Technol. Aralık 2023;7(2):139-143. doi:10.32571/ijct.1325830
Chicago Polat, Derya, Elif Pala, ve Filiz Gerçeker. “HIF-1α: A Potential Biomarker in Obstructive Sleep Apnea”. International Journal of Chemistry and Technology 7, sy. 2 (Aralık 2023): 139-43. https://doi.org/10.32571/ijct.1325830.
EndNote Polat D, Pala E, Gerçeker F (01 Aralık 2023) HIF-1α: a potential biomarker in obstructive sleep apnea. International Journal of Chemistry and Technology 7 2 139–143.
IEEE D. Polat, E. Pala, ve F. Gerçeker, “HIF-1α: a potential biomarker in obstructive sleep apnea”, Int. J. Chem. Technol., c. 7, sy. 2, ss. 139–143, 2023, doi: 10.32571/ijct.1325830.
ISNAD Polat, Derya vd. “HIF-1α: A Potential Biomarker in Obstructive Sleep Apnea”. International Journal of Chemistry and Technology 7/2 (Aralık 2023), 139-143. https://doi.org/10.32571/ijct.1325830.
JAMA Polat D, Pala E, Gerçeker F. HIF-1α: a potential biomarker in obstructive sleep apnea. Int. J. Chem. Technol. 2023;7:139–143.
MLA Polat, Derya vd. “HIF-1α: A Potential Biomarker in Obstructive Sleep Apnea”. International Journal of Chemistry and Technology, c. 7, sy. 2, 2023, ss. 139-43, doi:10.32571/ijct.1325830.
Vancouver Polat D, Pala E, Gerçeker F. HIF-1α: a potential biomarker in obstructive sleep apnea. Int. J. Chem. Technol. 2023;7(2):139-43.